Literature DB >> 12102610

Sarcoidosis presenting in patients older than 50 years.

Roberta Lenner1, Gregory J Schilero, Maria L Padilla, Alvin S Teirstein.   

Abstract

BACKGROUND: Sarcoidosis occurs most often between 20 and 40 years of age, but also presents in children and older adults. Newly diagnosed sarcoidosis in older patients has received little attention. In order to characterize sarcoidosis in older patients, the clinical, radiographic and laboratory features of sarcoidosis presenting in patients aged 50 or older were compared to patients whose sarcoidosis was diagnosed at an earlier age.
METHODS: The medical records of 181 consecutive patients with sarcoidosis were reviewed. They were divided into 92 patients diagnosed at 50 years of age or older (group A), and 89 whose diagnosis preceded age 50 (group B).
RESULTS: Comparison of group A with group B revealed that the two groups were similar with regard to race, gender, smoking habits, common presenting symptoms, organ system involvement, pulmonary function data, radiographic stage, PPD status, and laboratory values. At the time of diagnosis, most patients in both groups presented with either respiratory symptoms or asymptomatic chest roentgenogram abnormalities. The most prevalent pulmonary function abnormality was reduced diffusing capacity in both groups. Most patients exhibited either stage I or II chest roentgenograms. Organ systems most commonly involved included lung, lymph nodes, and skin.
CONCLUSION: Sarcoidosis presents with similar clinical features whether diagnosed in young adults or in patients over the age of 50. The diagnosis of sarcoidosis should be considered in patients presenting over age 50 with characteristic signs and symptoms including chest radiographic evidence of mediastinal lymphadenopathy.

Entities:  

Mesh:

Year:  2002        PMID: 12102610

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  7 in total

Review 1.  Elderly-onset sarcoidosis: prevalence, clinical course, and treatment.

Authors:  Yvan Jamilloux; Marc Bonnefoy; Dominique Valeyre; Loig Varron; Christiane Broussolle; Pascal Sève
Journal:  Drugs Aging       Date:  2013-12       Impact factor: 3.923

2.  Epidemiology of Sarcoidosis in a Prospective Cohort Study of U.S. Women.

Authors:  Orianne Dumas; Lisa Abramovitz; Aleta S Wiley; Yvette C Cozier; Carlos A Camargo
Journal:  Ann Am Thorac Soc       Date:  2016-01

3.  Clinical characteristics of sarcoidosis patients in the United States versus China.

Authors:  Zhou Ying; E Lower Elyse; Feng Yinping; Du Shanshan; Li Huiping; P Baughman Robert
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2020-03-09       Impact factor: 0.670

Review 4.  Sarcoid Uveitis: An Intriguing Challenger.

Authors:  Pia Allegri; Sara Olivari; Federico Rissotto; Roberta Rissotto
Journal:  Medicina (Kaunas)       Date:  2022-07-04       Impact factor: 2.948

5.  Clinical characteristics and computed tomography findings in Arab patients diagnosed with pulmonary sarcoidosis.

Authors:  Esam H Alhamad; Mohammed O Alanezi; Majdy M Idrees; Mohammad K Chaudhry; Ali M AlShahrani; Arthur Isnani; Shaffi Shaikh
Journal:  Ann Saudi Med       Date:  2009 Nov-Dec       Impact factor: 1.526

6.  Retrospective study of elderly onset sarcoidosis in Tunisian patients.

Authors:  Donia Chebbi; Sameh Marzouk; Mouna Snoussi; Moez Jallouli; Nawrez Gouiaa; Tahia Boudawara; Zouhir Bahloul
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2021-06-28       Impact factor: 0.670

7.  Nationwide survey on the organ-specific prevalence and its interaction with sarcoidosis in Japan.

Authors:  Takeshi Hattori; Satoshi Konno; Noriharu Shijubo; Tetsuo Yamaguchi; Yukihiko Sugiyama; Sakae Honma; Naohiko Inase; Yoichi M Ito; Masaharu Nishimura
Journal:  Sci Rep       Date:  2018-06-21       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.